4.4 Review

Nanomedicine and its potential in diabetes research and practice

期刊

DIABETES-METABOLISM RESEARCH AND REVIEWS
卷 24, 期 8, 页码 604-610

出版社

WILEY
DOI: 10.1002/dmrr.893

关键词

nanomedicine; glucose sensors; fluorescence; nanoparticles; insulin; single-molecule

资金

  1. Engineering and Physical Sciences Research Council
  2. Wellcome Trust
  3. Royal Society
  4. Wolfson Foundation
  5. Scottish Funding Council
  6. Higher Education Funding Council for England
  7. EPSRC [EP/D062861/1] Funding Source: UKRI
  8. Engineering and Physical Sciences Research Council [EP/D062861/1] Funding Source: researchfish

向作者/读者索取更多资源

Nanomedicine involves measurement and therapy at the level of 1-100 nm. Although the science is still in its infancy, it has major potential applications in diabetes. These include solving needs such as non-invasive glucose monitoring using implanted nanosensors, with key techniques being fluorescence resonance energy transfer (FRET) and fluorescence lifetime sensing, as well as new nano-encapsulation technologies for sensors such as layer-by-layer (LBL) films. The latter might also achieve better insulin delivery in diabetes by both improved islet encapsulation and oral insulin formulations. An artificial nanopancreas' could be an alternative closed-loop insulin delivery system. Other applications of nanomedicine include targeted molecular imaging in vivo (e.g. tissue complications) using quantum dots (QDs) or gold nanoparticles, and single-molecule detection for the study of molecular diversity in diabetes pathology. Copyright (C) 2008 John Wiley & Sons, Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据